WE ARE FANATICAL ABOUT DEVELOPING PERSONALIZED BIOMEDICAL IMPLANTS FOR INDIVIDUALS —
NOT THE MASSES.
We are world-class surgeon scientists, entrepreneurial leaders, and bioengineering and AI experts who have developed our core technology, built prototype devices, and scaled venture-backed healthcare companies to industry leadership.
If we were to change the trajectory of how surgical implants deliver value for patients in sub-specialties ranging from urologic, cardiac, orthopedic and even neural implants, we could change the outcomes for millions of patients worldwide.
We are committed to achieving the 3rd SDG: GOOD HEALTH AND WELL-BEING by leveraging our expertise and groundbreaking technologies to advance the field of surgery and positively impact the lives of patients worldwide.
.png?width=515&height=475&name=surgeons%20(2).png "surgeons (2)")
Incremental Improvements Don't Move Fast Enough
Despite the surgical implant market exceeding $50 billion, innovation has been stifled by incrementalism. The era of mass-produced implants is ending, as they fail to meet patient needs and often cause complications such as bleeding, tissue damage, infection, or even death.
The Problem
- Impersonal Treatments: Current implants do not cater to individual patient needs.
- Complications: High rates of bleeding, tissue damage, infection, and even death.
- Long, Painful, and Costly Recoveries: Patients endure extended recovery times that are both painful and expensive.
Our Experience
Our medical practitioners have witnessed the failures and disappointments of past implant generations produced by major medical device companies. The high failure rates are unacceptable, and the need for better solutions is clear.
The Solution
To ensure successful outcomes for patients undergoing cardiovascular, neurological, orthopedic, or urological surgeries, biocompatibility and material resilience are paramount. Optimization must surpass improvisation to achieve better patient outcomes, especially at critical care points.